Paul J Sabbatini

Sloan-Kettering Institute For Cancer Res

$3,542,584

Attributed

$3,542,584

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.9M · FY2005–19

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

Funding mix

By agency

NIH$9,944,956 · 3

By mechanism

P01$9,315,856 · 2

K23$629,100 · 1

Top collaborators

David R Spriggs5 shared

Most similar at Sloan-Kettering Institute For Cancer Res

Same institution · by research overlap

Richard J O'Reilly$17,498,839
Maria Jasin$27,633,261
David A Scheinberg$21,198,583
Philip O. Livingston$8,464,484
Paul Tempst$13,376,215

Others in their field

Top investigators on “Base”

Sonia M Thomas · Research Triangle Institute$700,865,642
David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
David Divins · Consortium For Ocean Leadership, Inc$609,772,544
Larry Arthur$521,411,998
Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060

Research focus

BaseImmuneCtag1 GeneVaccinesCancer PatientCancer TherapyWomanImmune SystemMalignant Neoplasm Of OvaryT-LymphocyteCause Of DeathMalignant NeoplasmsImmunologicsImmune Checkpoint BlockadeImmune TargetingAntigensCancer CellEffectivenessEffective TherapyBloodChemotherapyDisease RemissionEpithelial Ovarian CancerBlocking Antibodies